A dire shortage of more than 12 different HRT medications has prompted the Therapeutic Goods Administration to advise doctors to limit prescribing the medications for new patients.
HealthDay News — Fezolinetant is safe and effective for moderate-to-severe vasomotor symptoms (VMS), according to a study presented at the annual European Congress of Endocrinology, hosted by the ...